外高橋(600648.SH):外資管公司累計增持0.93%A股股份
格隆匯3月31日丨外高橋(600648.SH)公佈,公司於2025年3月31日收到外資管公司的通知,外資管公司自2024年12月31日至2025年3月31日通過上海證券交易所繫統以集中競價交易方式累計增持A股股份10,503,600股,增持金額為人民幣121,171,139.58元;上述增持股份佔公司總股本的0.93%。本次權益變動後,外資管公司持有公司股份比例由49.84%增加至50.77%,外資管公司及其一致行動人合計持有公司股份比例由56.07%增加至57%,持股比例觸及1%的整數倍。外資管公司的增持計劃尚未實施完畢,後續將按照增持計劃,繼續擇機增持公司A股股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.